Bioelectronics Corp (BIEL)

[srinsocal]

No, BIEL has been in Business close to 20 years now, the 11 years is the number of years that some have been predicting that BIEL would cease operations.

Quite a record, 11 Losses and Zero Wins.

When a company finances operations by selling shares in the company dilution will occur. A company can raise the Authorized Shares to accommodate this type of financing or a company can perform Reverse Splits which masks the dilution.

BIEL chose to increase the AS.

Our friends at Endonovo, also in the medical device business, ENDV, chose the RS path. A 1 for 100 RS in 2014, that one million shares you owned was now 10,000 shares. In 2019 ENDV did another RS this time 1 for 1,000. That 10,000 shares you owned was now 10 shares.

That $200,000 investment you made in 2014 is now worth less than $8 with ENDV currently selling for .0078. And they will need another RS soon to keep their OTCQB status which requires a 1 cent minimum stock price.

Using ENDV again for a Sales gauge:
ENDV - 2021 - $73k, 2020 - $165k
BIEL - 2021 - 1.6 million, 2020 - $829k


https://ir.endonovo.com/press-releases/detail/134/endonovo-therapeutics-affects-1-for-100-reverse-stock-split

https://www.globenewswire.com/news-release/2019/12/11/1959453/0/en/Endonovo-Therapeutics-Announces-Reverse-Stock-Split.html